Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Gains from Investment Securities (2022 - 2026)

Envoy Medical's Gains from Investment Securities history spans 5 years, with the latest figure at $12000.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 35.36% to $12000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$884000.0, a 10071.8% decrease, with the full-year FY2025 number at $348280.0, down 84.27% from a year prior.
  • Gains from Investment Securities hit $12000.0 in Q1 2026 for Envoy Medical, up from -$85000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for COCH hit a ceiling of $693000.0 in Q3 2025 and a floor of -$14.4 million in Q1 2022.
  • Historically, Gains from Investment Securities has averaged -$1.1 million across 5 years, with a median of -$37000.0 in 2025.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 576.67% in 2023 and later surged 1971.43% in 2024.
  • Tracing COCH's Gains from Investment Securities over 5 years: stood at -$30000.0 in 2022, then plummeted by 576.67% to -$203000.0 in 2023, then plummeted by 281.28% to -$774000.0 in 2024, then skyrocketed by 89.02% to -$85000.0 in 2025, then surged by 114.12% to $12000.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for COCH at $12000.0 in Q1 2026, -$85000.0 in Q4 2025, and $693000.0 in Q3 2025.